麻醉和喉罩市场：按细分市场划分的规模、份额、法规、报销、程序和 2033 年预测

患有慢性阻塞性肺病等呼吸系统疾病的大量老年族群是市场的关键驱动力。 联合国预测，到 2050 年，60 岁及以上人口将达到 20 亿，成长速度明显快于总人口成长速度，年增率约 3%（UNDESA，2017）。 人口老化影响健康和医疗保健，而医疗设备是医疗保健服务的重要组成部分。

此外，由于吸烟和空气品质差，全球患有慢性阻塞性肺病的人口持续成长。 据估计，全球有超过2亿人患有慢性阻塞性肺病，其中超过6,500万人患有中度至重度慢性阻塞性肺病。 慢性阻塞性肺病是全球第三大死因。 麻醉和喉罩与急慢性呼吸道疾病的治疗领域高度相关。 一项研究表明，慢性阻塞性肺病患者使用长期非侵入性通气可将相对死亡风险降低 60% 以上。

由于COPD患者数量的增加，急诊医院市场和家庭医疗市场规模不断扩大。 麻醉面罩和喉罩通常用于医院、家庭环境和疗养院，作为非侵入性呼吸器和气道正压装置的病人介面。 这些面罩可从设备製造商和第三方供应商处取得。 不同介面的选择取决于通气的有效性和患者对通气的耐受性。

本报告深入探讨了全球麻醉和喉罩市场，包括竞争格局、SWOT 分析、到 2033 年的市场预测、COVID-19 的影响、区域和国家趋势等。

目录

目前麻醉喉罩市场及竞争状况

• 对主要产业趋势的见解
• 2015 年至 2033 年麻醉及喉罩各细分市场的市场总收入及市场前景
• 按细分市场划分的手术总数、单位数量、平均售价和市场价值的详细数据

全球、区域与国家见解

• 麻醉及喉罩市场SWOT分析
• 麻醉和喉罩市场的竞争动态洞察和趋势
• 各国医疗保健系统概览
• 按国家/地区划分的报销政策
• 各国医疗科技的监管状况

Anesthesia and Laryngeal Masks Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Anesthesia and Respiratory Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Anesthesia and Laryngeal Masks market for the year 2020 and beyond. The large geriatric population base, suffering from respiratory diseases such as COPD, is the primary driver of the market. The United Nations estimates that the population of individuals of ages over 60 will reach two billion in 2050 with a growth rate of about 3% annually, considerably faster than the population as a whole (UNDESA, 2017). Population aging affects health and healthcare, and medical devices are a crucial component of healthcare delivery.

In addition, the global population with COPD continues to expand due to smoking and poor air quality. More than 200 million people worldwide are estimated to have COPD, including more than 65 million moderate-to-severe COPD patients (Ferkol and Schraufnagel, 2014). COPD is the third leading cause of death globally (World Health Organization, 2014). Anesthesia and Laryngeal Masks are highly involved with the therapeutic areas for acute and chronic respiratory diseases. A study showed that mortality risk reduced by over 60% on a relative basis using long-term non-invasive ventilation for COPD patients (Kohnlein et al., 2014). patients also experienced an improvement in quality of life and exercise capacity.

The rising number of COPD patients results in an increase in the size of the acute care hospitals market and the home care market. Anesthesia and Laryngeal Masks are commonly used in hospitals, home settings, and long-term care facilities, as patient interfaces for non-invasive ventilators or positive airway pressure devices. They are available from device manufacturers and third party suppliers. The choice of different interfaces depends on ventilation efficacy and the patient's tolerance of the ventilation.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Anesthesia and Laryngeal Masks and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Anesthesia and Laryngeal Masks market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Anesthesia and Laryngeal Masks market.
• Competitive dynamics insights and trends provided for Anesthesia and Laryngeal Masks market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Teleflex Inc, Intersurgical Ltd., Medline Industries Inc, Ambu A/S, Medtronic Plc, Vyaire Medical Inc, ICU Medical Inc, Flexicare Group Ltd, Draegerwerk AG & Co KGaA, Jiangsu Weikang Jiejing Medical Apparatus Co Ltd, Cardinal Health Inc, Vygon SA and Others

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Anesthesia and Laryngeal Masks marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Anesthesia & Laryngeal Masks market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Anesthesia & Laryngeal Masks market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Anesthesia & Laryngeal Masks market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Anesthesia & Laryngeal Masks market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable